PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion. - Wikidata - wikimedia - TriplyDB

PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

http://www.wikidata.org/entity/Q37007388

about

A Soluble Form of P Selectin Glycoprotein Ligand 1 Requires Signaling by Nuclear Factor Erythroid 2-Related Factor 2 to Protect Liver Transplant Endothelial Cells Against Ischemia-Reperfusion Injury.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.PSGL-1: A New Player in the Immune Checkpoint Landscape.Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.Targeting the PSGL-1 pathway for immune modulation.CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation.Telomere Dynamics in Immune Senescence and Exhaustion Triggered by Chronic Viral Infection.Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease.Trial watch: Immune checkpoint blockers for cancer therapy.Selectins in cancer immunity.Immuno-Oncology: Emerging Targets and Combination Therapies

P2860

Q38407585-CE244C7C-966C-48B3-B8A0-05D6E1304B62 Q38873974-0E8A549E-3827-4F6E-8815-9A5549042AB1 Q39163377-F81D2330-8974-4664-BD0C-BF40C813C692 Q39294808-D49773B8-3015-4B56-BF72-12FC8862AFFB Q40064187-08BF3D85-28CC-436D-8A5C-3966691B97B2 Q40160482-21A053F9-9D79-42C3-B981-F9A2E218E394 Q41923721-BF99DC15-5C40-466F-916F-99AFA3CDC7EE Q42379668-292E6E31-A0B3-43D8-9260-F005FDE90761 Q47393365-F401E0CA-9C3C-4387-9F98-58320AEA7A88 Q49617012-8955045F-C127-4B6A-AF38-28A48A0FD3CC Q56889817-A0493273-BEB0-4CA3-9802-E41655FB66C6

P2860

PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

http://www.wikidata.org/entity/Q37007388

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

@en

PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

@nl

type

label

PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

@en

PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

@nl

prefLabel

PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

@en

PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

@nl

P1433

Q37007388-AFF3614C-196B-4BBE-A2C3-C1BCAE2788EC

P1476

Q37007388-44407435-5E71-43A7-A9E8-FDC0F3C4BA8E

P2093

Q37007388-15BE7E93-9271-4621-BEB6-7B620CE85149

Q37007388-372065E7-44D8-4782-9911-923522F7E6F1

Q37007388-410409C4-B116-451C-86FB-BBD1858E1DB8

Q37007388-61DB9BED-1E4D-40CA-B9C8-F21C8871275D

Q37007388-858041D6-1BE6-4094-8E40-CAAB61AE1073

Q37007388-99968153-ADA4-4216-BE32-F6A86EECA9C8

Q37007388-DA650287-7459-4738-9D76-1F5D0B5FF85A

P2860

Q37007388-07B7EA89-F7BC-4A61-8CD2-B90B756EA68F

Q37007388-0DE2FBCA-7072-4D00-84F1-616E1F7C8E50

Q37007388-0E14E03A-8466-4DE1-8643-D8970AC7012A

Q37007388-0E4229A6-F8DE-4F2C-B9A3-61C175BB61C3

Q37007388-12544552-4FA9-437B-94AD-941ACFA07D7A

Q37007388-187F4A2F-1DBC-430C-89F1-A1255473C065

Q37007388-200BF0F8-D3C4-4F4E-BE17-D8F2BB0F598C

Q37007388-20BCAF92-1010-412F-A1CF-A80F89C2B035

Q37007388-2756302A-615A-43B7-8453-C66545ABA7B7

Q37007388-2A549767-079D-4EFA-9A0C-3FF448B71C5D

P304

Q37007388-72D323C9-D2EC-4157-BB5C-44E395371020

P31

Q37007388-6D2D9275-B7C9-48F1-B1D8-7BB149A57057

P356

Q37007388-A81ECC19-6FDE-4A11-AF74-A5E5E4018CB7

P407

Q37007388-F504D19C-35A7-434D-B0F6-A9A3D1EC61D3

P433

Q37007388-778DDF0D-6BD9-4549-85A2-F4DF560FB40E

P478

Q37007388-FB55F208-C943-471B-AE85-14AAB4FCE136

P50

Q37007388-BA413A45-A2AB-475F-A1F7-95A30D36B98F

P577

Q37007388-BEF48ED3-D9C4-4A42-8449-5D17C2B0E642

P698

Q37007388-1BE4BDF8-5D85-4505-AB87-A007417A583B

P932

Q37007388-069B317A-0DA6-4201-BB4B-ED1230C10562

P356

J.IMMUNI.2016.04.015

P1433

P1476

PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

@en

P2093

Dennis C Otero

http://www.w3.org/2001/XMLSchema#string

Florent Carrette

http://www.w3.org/2001/XMLSchema#string

Jonathan Magaña

http://www.w3.org/2001/XMLSchema#string

Linda M Bradley

http://www.w3.org/2001/XMLSchema#string

Marcus W Bosenberg

http://www.w3.org/2001/XMLSchema#string

Monique L Barraza

http://www.w3.org/2001/XMLSchema#string

Susan L Swain

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Viral immune evasion due to persistence of activated T cells without effector function

Innate and adaptive immune cells in the tumor microenvironment

Interleukin-10 determines viral clearance or persistence in vivo

Nivolumab plus ipilimumab in advanced melanoma.

PD-1 and its ligands in tolerance and immunity

Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses

Restoring function in exhausted CD8 T cells during chronic viral infection

Getting to the site of inflammation: the leukocyte adhesion cascade updated

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

P304

1190-1203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2016.04.015

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27192578

http://www.w3.org/2001/XMLSchema#string

P932

4908967

http://www.w3.org/2001/XMLSchema#string